title: Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci.
abstract: Loss of HLA antigen expression is considered to be one of the mechanisms whereby tumor cells escape immune surveillance. We recently observed reduced or lost expression of HLA antigens during human colon carcinogenesis. We studied the effect of bile acids (BAs), long implicated in the pathogenesis of colon cancer, on the expression of HLA class I antigens in human colon adenocarcinoma cells. Lithocholic acid (LCA) decreased by 42% the expression of HLA class I antigens on the surface of these cells. This dose-dependent reduction was specific for both the target genes and the chemical structure of LCA, and was not evident in cultured liver cells. None of the other BAs that were tested manifested this effect. LCA, and to a lesser extent deoxycholic acid (DCA), decreased steady-state HLA class I mRNA levels. LCA decreased the rate of transcription of HLA-B (64%) and HLA-C (87%) but not HLA-A; DCA had a similar but less pronounced effect. In transient gene expression (CAT assays) experiments, we evaluated the role of a 0.6-0.7 kb EcoRI/XbaI sequence from the 5' flanking region of HLA-A2, -B7 and -Cw7 genes in the regulation of class I gene expression by LCA. LCA down-regulated by 70% the expression of the reporter gene for all three genes. We interpret these results as indicating a differential regulation of the three HLA loci by LCA. Our findings, demonstrating a profound effect of LCA on HLA class I gene regulation, raise the possibility that such a mechanism may be operative in vivo.
authors.affiliation: Department of Medicine, Cornell University Medical College, New York, NY 10021.
authors.forename: P
authors.initials: P
authors.lastname: Arvind
authors.forename: E D
authors.initials: ED
authors.lastname: Papavassiliou
authors.forename: G J
authors.initials: GJ
authors.lastname: Tsioulias
authors.forename: B W
authors.initials: BW
authors.lastname: Duceman
authors.forename: C I
authors.initials: CI
authors.lastname: Lovelace
authors.forename: W
authors.initials: W
authors.lastname: Geng
authors.forename: L
authors.initials: L
authors.lastname: Staiano-Coico
authors.forename: B
authors.initials: B
authors.lastname: Rigas
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology*; D001483:Base Sequence; D001647:Bile Acids and Salts / Q000502:physiology; D003110:Colonic Neoplasms / Q000276:immunology*; D015536:Down-Regulation / Q000276:immunology; D015972:Gene Expression Regulation, Neoplastic / Q000276:immunology; D005805:Genes, MHC Class I; D006680:HLA Antigens / Q000096:biosynthesis* / Q000235:genetics; D015234:HLA-A Antigens / Q000096:biosynthesis; D015235:HLA-B Antigens / Q000096:biosynthesis; D015236:HLA-C Antigens / Q000096:biosynthesis; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008095:Lithocholic Acid / Q000502:physiology*; D008969:Molecular Sequence Data; D014158:Transcription, Genetic / Q000276:immunology; D014407:Tumor Cells, Cultured
chemical_list: D001647:Bile Acids and Salts; D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D015395:Histocompatibility Antigens Class I; D008095:Lithocholic Acid